Lauric acid provides neuroprotection against oxidative stress in mouse model of hyperglycaemic stroke.
Mice
Animals
Neuroprotection
Brain Edema
Hyperglycemia
/ complications
Neuroprotective Agents
/ pharmacology
Stroke
/ drug therapy
Oxidative Stress
Brain Ischemia
/ metabolism
Disease Models, Animal
Superoxide Dismutase
/ metabolism
Superoxide Dismutase-1
/ metabolism
Glucose
/ pharmacology
Ischemic Stroke
Infarction
Hyperglycemia
Lauric acid
Neuroinflammation
Neuroprotection
Oxidative stress
Permanent middle cerebral artery occlusion
Saturated fatty acid
Journal
European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354
Informations de publication
Date de publication:
05 Oct 2023
05 Oct 2023
Historique:
received:
06
06
2023
revised:
10
08
2023
accepted:
10
08
2023
medline:
31
8
2023
pubmed:
13
8
2023
entrez:
12
8
2023
Statut:
ppublish
Résumé
During ischemic stroke, higher glucose level linked worse outcomes were reported even in patients without pre-existing diabetes. Evidence suggest that such worse stroke outcomes were mainly due to production of reactive, toxic glucose metabolites that expands oxidative damage inside the brain. As a consequence of high oxidative stress, microvasculature structures and tight junctions compromised their functionally, infarct volume expands and brain edema exacerbates. In a mouse model of ischemic stroke with induced acute hyperglycaemia, Lauric acid (LA) as a natural saturated fatty acid demonstrated neuroprotection by attenuating infarct volume and brain edema. In addition, in the ipsilateral hyperglycaemic brain, the LA significantly increased the expression of tight junction representative protein (occludin) as well as anti-oxidative markers; Manganese superoxide dismutase (Mn) SOD, Extracellular superoxide dismutase (Ec-SOD) and nuclear factor-erythroid factor 2-related factor 2 (Nrf2) in the ipsilateral region against hyperglycemic ischemic stroke. LA treated animals showed a significant reduction in the production of lipid peroxidation products (4-HNE) in the microvascular structures, maintained the blood brain barrier (BBB) integrity. LA linked neuroprotective outcomes were further confirmed by behavioral tests, where functional outcomes and motor coordination were improved significantly. Furthermore, LA treatment enhanced food intake, decreased mortality rate, and net body weight loss. Conclusively, LA modulated ischemic insult exacerbated by hyperglycemia and provided neuroprotection.
Identifiants
pubmed: 37572940
pii: S0014-2999(23)00502-2
doi: 10.1016/j.ejphar.2023.175990
pii:
doi:
Substances chimiques
lauric acid
1160N9NU9U
Neuroprotective Agents
0
Superoxide Dismutase
EC 1.15.1.1
Superoxide Dismutase-1
EC 1.15.1.1
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
175990Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest All the authors declare no conflict of interest.